Yifan Pharmaceutical Co., Ltd. (SHE:002019)

Market Cap	12.42B -3.1%
Revenue (ttm)	5.22B +4.6%
Net Income	407.37M
EPS	0.34
Shares Out	1.04B
PE Ratio	35.26
Forward PE	23.49
Dividend	0.10 (0.82%)
Ex-Dividend Date	May 29, 2025

Volume	8,761,335
Average Volume	13,841,790
Open	12.33
Previous Close	11.83
Day's Range	11.83 - 12.33
52-Week Range	9.98 - 16.66
Beta	0.92
RSI	38.42
Earnings Date	Apr 24, 2026

About Yifan Pharmaceutical

Yifan Pharmaceutical Co., Ltd. engages in the research and development, production, and sale of pharmaceutical products, raw materials, and polymer materials in Southeast Asia, Europe and North America, Singapore, South Korea, Italy, China, Germany, and the United States. It offers Chinese patent medicines, chemical medicines and biological medicines; and vitamin products, including vitamin B5 and original B5. The company was formerly known as Yifan Xinfu Pharmaceutical Co., Ltd. and changed its name to Yifan Pharmaceutical Co., Ltd. in October...

• Industry: Drug Manufacturers - General
• Sector: Healthcare
• Founded: 2000
• Employees: 4,098
• Stock Exchange: Shenzhen Stock Exchange
• Ticker Symbol: 002019